A recent clinical trial conducted by Soroka University Medical Center and Israeli medical cannabis company Cannbit-Tikun Olam (TASE:TKUN) showed promising results, especially for treating post-traumatic stress disorder (PTSD), reported the Jerusalem Post.
Notably, a number of cannabis-medicated patients stopped or reduced their dosages of opioids by 52%, anti-psychotics by 36.9%, anti-epileptics by 35.7% and hypnotics and sedatives by 35.3%. Overall, over two-thirds of patients reported at least moderate improvement with no serious side effects, with 90.8% of treated PTSD patients being classified as therapeutic successes after six months.
Other benefits included a decrease in rage attacks, restlessness, nausea and sleep disturbances. Nearly half of the patients reported that their quality of life had improved during the time of treatment.
The study, conducted over several years, focused on 8,500 male and female Israelis, averaging 54.6 years old, using marijuana strains developed by Cannbit-Tikun Olam.
“In the past, we already demonstrated that treatment with medical cannabis products relieves symptoms and improves quality of life for patients,” said Lihi Bar-Lev Schleider the company’s head of R&D. “This is the first time that in-depth, organized and systematic analysis of a large amount of data on a very large group of patients was performed, and in which, without bias, the effect of the treatment for various indications was examined.”
In December last year, an exclusive and mutual collaboration agreement was signed by Cannbit-Tikun Olam and Teva Pharmaceuticals, wherein the former’s products will be distributed by the latter throughout Israel and the Palestinian Authority.
“The medical cannabis arena is developing and being professionalized at a dizzying pace in Israel, and there is more openness to it in Israel and worldwide,” Teva Israel CEO Yossi Ofek said.
“Today, it is clear to many in the pharmaceutical industry and in the medical community that the use of oils produced from specific cannabis strains may provide additional treatment options and respond to unmet medical needs of patients. I have no doubt that the medical cannabis oils Cannbit-Tikun Olam produces – according to Teva’s high quality and safety standards – will help us realize our goal of improving the lives of patients.”
The emergency legislation is meant to ease logistical burdens for medical marijuana patients and encourage people to get their cannabis from licensed dispensaries.
It is about to become much easier for senior citizens to register for medical marijuana in Washington D.C.
Mayor Muriel Bowser has signed a bill into law that will expand access to the District’s medical marijuana program in a series of ways.
Photo by rawpixel.com
For starters, people 65 and older can “self-certify that they will use cannabis for medical purposes in lieu of including a recommendation from their health care practitioner with their registration application as is required for all other applicants,” the administration said.
The law also extends the registration renewal deadline for other patients and creates a week-long medical marijuana tax “holiday” that happens to coincide with 4/20.
It is about to become much easier for senior citizens to register for medical marijuana in Washington D.C.
Mayor Muriel Bowser has signed a bill into law that will expand access to the District’s medical marijuana program in a series of ways.
For starters, people 65 and older can “self-certify that they will use cannabis for medical purposes in lieu of including a recommendation from their health care practitioner with their registration application as is required for all other applicants,” the administration said.
The law also extends the registration renewal deadline for other patients and creates a week-long medical marijuana tax “holiday” that happens to coincide with 4/20.
Senior Week is part of the Medical Marijuana Patient Access Extension Emergency Amendment Act of 2022, which Mayor Bowser signed into law last week.
There’s more: Patient and caregiver registrations issued through Sept. 30 will be good for two years, which is double the usual term; the registration fees are already waived through April 24 and medical cannabis products purchased at any of D.C.’s seven licensed dispensaries will be exempt from the 6% sales tax.
The emergency legislation is meant to ease logistical burdens for medical marijuana patients and encourage people to get their cannabis from licensed dispensaries, rather than the gray market vendors.
The New York Senate passed a bill Tuesday that would provide provisional marijuana cultivator and processor licenses to existing hemp businesses that take specific steps to promote equity in the emerging industry, Marijuana Moment reported.
The bill, sponsored by Sen. Michelle Hinchey (D) and approved in a 50-13 vote, seeks to both speed up the process of starting New York’s adult-use market, and support efforts to reach equity goals with respect to cannabis business participation.
“I’m proud to sponsor legislation to help them obtain conditional licenses, which will allow New York to implement its cannabis program faster,” Senator Hinchey said. “Our existing hemp growers, who have been some of the hardest hit by market fluctuations, already have the knowledge base to meet this need, and I’m proud to sponsor legislation to help them obtain conditional licenses, which will allow New York to implement its cannabis program faster.”
Hinchey pointed out that New York state’s cannabis program aims to create an industry predicated on social equity, inclusion and one that ensures local economic success. “To achieve these goals and create a truly circular economy, we need New York farmers to begin the growing process now so that when cannabis dispensaries open, we can fill shelves with quality New York-grown products.”
The Assembly is taking up an identical companion measure on Wednesday, which could result in legislation being sent to the governor’s desk. Assembly Majority Leader Crystal Peoples-Stokes (D) is sponsoring the chamber’s version of the licensing bill.
While regulators are still finalizing licensing rules, and with no retailers yet authorized to sell recreational marijuana, adults 21 and older can legally possess and publicly consume cannabis and gift it to other adults, without compensation.
While hemp stakeholders in the Bluegrass State claim that delta-8 THC is legal under the legislation’s provisions, regulators emphasize that the compound is not naturally derived from the hemp plant.
The Kentucky legislature is seeking to ban all forms of “intoxicating products” made from industrial hemp, such as delta-8 THC, a form of THC distinguished from the more common delta-9 THC found in cannabis plants, Hemp Today writes.
According to a bill proposed this week, smokable hemp would also be prohibited by the law — in the form of cigarettes or cigars — as well as smokeless products including chew or dip, whole hemp buds, hemp teas and ground hemp flowers and leaves.
The legislation, which expands existing language in the state’s law, is also designed to outlaw other hemp-derived minor cannabinoids like delta-10 THC, THC-O, and THC-P, as per an unofficial copy of the proposal.
While hemp stakeholders in the Bluegrass State have been interpreting the 2018 Farm Bill to their favor, claiming that delta-8 THC is legal under the legislation’s provisions, regulators have pushed back, emphasizing that the compound is not naturally derived from the hemp plant.
The Kentucky Hemp Association highlighted that a ban on delta-8 THC would result in the loss of potentially billions of dollars by Kentucky’s cannabis economy, including growers, producers and retail operators.
New surveys show that sex and relationships are facing an all-time low.
On Valentine’s Day, it seems the country is at a 30 year low for sex and living together, with marriages and partnerships decreasing the younger people are. The finding is from a published General Social Survey, which uncovered some curious findings showing a generational change when it comes to dating and romance.
The survey’s results show the low numbers aren’t due to the pandemic. This trend has been ongoing for years, with every new survey reinforcing it. In 2021, 26% of Americans over the age of 18 hadn’t had sex over the past year. While this percentage was higher than previous years, surveys in 2016 and 2018 came in at 23%.
CNN argues that this phenomenon isn’t limited to sex. Numbers from Pew Research Center say that 62% of Americans between the ages of 25 to 54 were married or living with a partner, a lower number than in previous years. According to Pew polling, it appears the economy is impacting people’s decision to marry, with a lot of them saying that they won’t get married if it’s not financially feasible.
Lastly, results show that this trend has more to do with people’s mindsets than their ages. People over the age of 55 continue to have the same partnership and sex trends as they did 30 years ago. It’s younger people whose interests have waned.
While news like this tends to cause alarm for a lot of people, particularly those who are older, maybe we shouldn’t start calling for the end of humanity just yet.
A lot of single people today are happier and more empowered than they were before, shifting their priorities until the time is right for them or they have fulfilled their professional achievements. Maybe the prospect of marriage and kids is less enticing when the economy is falling, we’re in the middle of a pandemic and the threat of global warming lurks around the corner.
In Texas, only three companies are authorized to supply cannabis for the state’s medical program, while state officials in Oklahoma have licensed some 12,000 marijuana-related businesses.
Texas’ Compassionate Use Program remains one of the most restrictive in the U.S. Through the program, the Department of Public Safety operates a secure online registry of qualified physicians who can prescribe low tetrahydrocannabinol (THC) to patients with specific medical conditions.
The Compassionate Use Registry of Texas (CURT) is designed to prevent more than one qualified physician from registering as the prescriber for a single patient, and is accessible to law enforcement agencies and dispensing organizations to verify patients of low-THC cannabis.
Photo by Bo Zaunders/Getty Images
Meanwhile, across state lines in Oklahoma, where voters legalized medical marijuana in 2018, is experiencing a weed-industry boom, reported NBC News. The medical cannabis market in the Sooner State generated about $150 million in 2021 revenue.
In Texas, only three companies are authorized to supply cannabis for the state’s medical program. However, in Oklahoma, state officials have licensed some 12,000 marijuana-related businesses, and about 1 in 10 people has medical marijuana cards.
Oklahoma’s Republican Governor Kevin Stitt pointed to the relatively low cost of obtaining a cannabis business license, noting that without a cap on marijuana operators, the market has expanded at an unsustainable rate.
“Oklahoma charges just $2,500 for a commercial license,” Stitt said, noting that California charges far more, in fact up to 72 times more. “As a result, we have seven times the growers in California with just 10 percent of the people.
Next door in Arkansas, they have eight growers. We have 8,300,” the governor said. “You know as well as I do that not all of that product is being sold legally. This is a perfect example of why we need to make sure initiative petitions represent Oklahomans and not out-of-state special interest groups,” added the Governor.
Photo by LPETTET/Getty Images
Morgan Fox, political director of NORML, said the system rightly favors small businesses.
“This is a system that is set up to basically create opportunities for small businesses,” Fox said. “There’s a lot of room for people to start up businesses without a tremendous amount of capital.”
Paulie Wood, a former California grower and the CEO of Kannabiz Monkeeyz told NBC that he decided to close his West Coast operations because of the “insane over-taxation” and headed for Oklahoma.
“In Oklahoma, you can literally start a grow for under $10,000, whereas in California you’re going to be out hundreds of thousands of dollars to just getting started,” Wood added. “They call it the wild west of cannabis. It’s the nicest, friendliest state we could ever want to be in.”
Oklahoma grower Josh Blevins told NBC that he and other growers regularly serve Texas customers who make the drive to purchase legal cannabis.
Want to make the most of your weed? Here’s how compact discs, honey, pennies, and other common objects can help.
By the time you’ve become a seasoned marijuana consumer, you’ll likely learn all of the little tricks you need to help make the most of your weed. From extending the life of your stash, grinding your own flower when you’re in a pinch, and enhancing your experience in general, here are some hacks that will improve your smoking significantly.
When the munchies strike, there’s very little you can do except indulge. Seasoned cannabis users usually learn to curb their urges, but for newcomers, mints are a good option. Mints can help you focus on something else, distracting you from the urge of eating food. Just like people who stop smoking tend to chew gum, mints can help keep your mind off blowing your diet.
A Penny
Photo by Elsa Olofsson via Unsplash
While you should always invest in a grinder, there are ways of cutting your marijuana neatly and evenly when in a bind. Take a penny and clean it thoroughly, then put your marijuana in a pillbox, drop the penny inside, close it up, and shake. Keep on shaking. After a vigorous workout, you’ll be left with some evenly cut marijuana.
Honey is a great companion for marijuana. After you’ve finished rolling up a joint or a blunt, be sure to coat it with a small amount of honey. This will ensure that your joint/blunt burns more slowly and evenly while also adding some sweetness.
Compact and Floppy Discs
Photo by Sharon McCutcheon via Unsplash
If you’re visiting your parents’ house, you’ll probably run into some floppy discs. These can be used to neatly pack bowls by using the middle hole of the discs. Easy, fast, and you’ll give use to something that is otherwise trash.
While there are many studies that exist pointing to the ability of cannabis compounds to aid in COVID recovery, we have to keep in mind that many of them are still in their infancy.
COVID-19 has taken countless lives worldwide, but thankfully with the vaccine, many have also been able to survive it.
However, surviving COVID-19 is not an easy feat. In many cases, the dreaded virus leaves damage in the bodies which we can feel for far long after we have tested negative. There are the usual symptoms such as dry cough, fever, colds, and shortness of breath.
Photo by engin akyurt via Unsplash
The duration and severity of symptoms differs from one person to another, but there are also some people who will experience symptoms that will linger for a longer period of time. Depending on the case, the fatigue, shortness of breath, difficulty breathing, chest pains, stomach pains, brain fog, muscle pain, headaches, and heart palpitations among others.
When the symptoms persist for as long as 12 weeks after the infection, this is known as long COVID, and these conditions are not yet well understood. Doctors and researchers don’t know why it happens, who it will happen to, and how to prevent it. Of course, getting your vaccine helps reduce any complications, and a booster shot even if you have gotten COVID will also help.
There is not much you can do to help treat it other than rest as much as you can, and for as long as it takes. Additionally, seeing your doctor to check for any complications will also help. These can prevent us from going back to a normal, healthy life. But what else can we do?
How Cannabis Can Aid In COVID Recovery
The compounds in cannabis, tetrahydrocannabinol (THC) and cannabidiol (CBD), have both shown to be promising in earlier studies for preventing and treating COVID. There are also hundreds of other compounds within the cannabis plant called cannabinoids that can help, like aiding in quicker recovery.
A 2021 study found that CBD, as well as another cannabinoid known as cannabivarin (CVN), can help treat long COVID. Researchers for the study found that when CBD and CVN are taken together, they work to down-regulate the proteins known as ACE2, TSP, NRP1, and IL-6, which COVID up-regulates or damages during the infection.
Another 2021 study, conducted by researchers at the Rabin Medical Center, analyzed the impact of CBD on 11 patients with serious COVID. Eight patients reported improvements in the infections. However, Dr. Moshe Yeshurun, who heads the hospital’s bone marrow unit, said that the findings required more research with a larger group of participants.
“After giving the cannabis oil we saw a drop in signs of the infection and this is definitely encouraging and gives a foundation to continue the research,” said Dr. Iliya Kagan, who oversees the Intensive Care Unit of the hospital. Kagan explains that once the CBD oil was given to the patients, it seemed to stop “although it is still premature to determine with certainty that it is a result of the cannabis.”
Another study from Austria, where doctors were using cannabis to treat COVID patients, found that CBD was promising as a treatment. “We administered CBD to 50 patients and observed that the infection levels disappeared more quickly,” said Dr. Rudolf Likar, who oversees the Department of Anesthesiology and Intensive Medicine at the Klagenfurt Hospital, the only clinic in Austria that uses CBD to treat COVID-19 patients.
Photo by Yarygin/Getty Images
He and his team began administering 200mg of CBD to ICU patients, then eventually increased the dosage up to 300MG, for three weeks. They found that the patient group who was given CBD healed from the COVID virus much faster compared to those who were given other medications.
They explained that CBD could be helpful in boosting the immune system because of its anti-inflammatory compounds. Their objective with COVID-19 therapy was to prevent other complications and even death.
The researchers at Oregon State University utilized a screening tool to discover these compounds, which had possessed the molecular properties they were looking for, which had the potential for blocking the spike protein of the virus from binding to a human cell.
The compounds were first tested in a petri dish with human cells. They used epithelial cells which are the cells that are found to line the walls of tissues including the lungs. Both the cannabinoids were found to reduce the ability of the protein to bind to epithelial cells which works the same way that monoclonal antibodies do, which are found in known COVID-19 treatments.
Photo by Fusion Medical Animation via Unsplash
“CBDA and CBGA are produced by the hemp plant as precursors to CBD and CBG, which are familiar to many consumers. however, they are different from the acids and are not contained in hemp products,” said Richard van Breemen, lead researcher for the study. “These compounds can be taken orally and have a long history of safe use in humans,” he adds. “They have the potential to prevent as well as treat infection by SARS-CoV-2.”
Conclusion
While there are many studies that exist pointing to the ability of cannabis compounds to aid in COVID recovery, we have to keep in mind that many of them are still in their infancy.
There’s still a lot we don’t know about how COVID mutates and reacts, but if you are interested in using CBD to aid in your recovery, it can be done under the supervision of your doctor who can advise you with the proper consumption methods for this.
“[The bill] will ensure the little guy — especially those most disadvantaged by the prohibition on cannabis — receive the seed funding and startup support necessary to slingshot small Virginia businesses into economic success,” said Sen. Adam Ebbin.
Adults in Virginia will be able to legally buy cannabis starting on Sept. 15 if a 451-page bill passed by the state Senate on Tuesday afternoon becomes law. Though its path remains uncertain in the House of Delegates, where the GOP-controlled committees have so far avoided taking up the issue, the bill would launch recreational marijuana sales early by letting current medical cannabis and hemp businesses enter the adult-use market.
A handful of companies would be able to begin selling cannabis in September under the bill from Sen. Adam Ebbin (D-Alexandria): the three companies that currently control Virginia’s medical marijuana market (MMJ) as well as up to ten registered, industrial hemp processors, reported the local public radio network VPM.
Under current law, medical marijuana processors in Virginia are allowed to open five additional retail sites aside from the place where they grow and process cannabis. Those stores would also be allowed to sell to all adult customers under Ebbin’s bill. The industrial hemp sites would be allowed to open up two additional retail sites aside from the place where they grow marijuana.
Other retailers would have to wait nearly 15 months, until January of 2024, to begin sales. Ebbin says the transition period will help curb the black market. Ebbin’s bill requires medical marijuana companies to “incubate five qualified social equity applicant retailers for a period of six months or support and educate qualified social equity applicants that wish to participate in the cannabis market.”
“It will ensure the little guy — especially those most disadvantaged by the prohibition on cannabis — receive the seed funding and startup support necessary to slingshot small Virginia businesses into economic success,” Ebbin said.
Equity and free-market advocates have pushed for everyone to start at the same time, arguing that the headstart gives big players an unfair advantage. In a report published last week, the Minority Cannabis Business Association noted similar arrangements in other states have resulted in “a lack of diversity and the proliferation of the legacy market.”
Despite its complexity, the Senate spent less than 20 minutes debating Ebbin’s bill. Three Republicans voted in favor of the bill and one Democrat sat out the vote.
A pair of studies show that while boosters provide protection from the virus, their effectiveness wanes over time.
COVID-19 boosters extend the protection granted by COVID-19 shots. But for how long? Two new studies found that while boosters protect a significant amount, their benefits wane after a certain amount of time.
Researchers examined the records of more than 200,000 visits to the emergency room and urgent care and over 90,000 hospitalizations, all taking place between August 2021 and January 2022. Researchers were able to notice more protection after patients had their third dose but were also able to pinpoint the moment where protection waned.
Two months after the third dose, there was 87% protection in emergency and urgent care visits, and 91% protection against hospitalizations. By the fourth month, these numbers fell to 66% and 78% respectively.
Evidence of waning immunity was not only present in Omicron cases. Previous data, from the time when Delta was the dominant strain, also showed that patients lost their immunity with the passage of time.
The CDC concluded their findings by stating that the “underscore the importance of receiving a third dose of mRNA COVID-19 vaccine to prevent both COVID-19-associated ED/UC encounters and COVID-19 hospitalizations among adults.”
